Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has released an investor presentation for the quarter ended September 30, 2026, highlighting sustainable growth in its core business, expansion into strategic categories, and strategic pillars such as portfolio strengthening, brand building, and operational excellence.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has fixed 7th November, 2026 as the record date for payment of the 1st Interim Dividend for the financial year 2026-27.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a net profit of Rs. 2,916.53 lakhs. The company has also declared a first interim dividend of Re.1/- per share for the financial year 2026-27.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has scheduled a Board Meeting on 03/11/2026 to consider and approve Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2026, and to declare 1st Interim Dividend 2026-2027.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has received an ESG rating of 'Adequate' with a score of 60 from CRISIL ESG Ratings & Analytics Limited, based on public disclosures and other available information.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has submitted a compliance certificate under Regulation 74 (5) of the SEBI (Depository Participants) Regulation, 2018, for the quarter ended 30/09/2026.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has closed its trading window for the quarter ending September 30, 2026, as per SEBI regulations and the company's code of conduct. The trading window will remain closed for the designated persons from October 1, 2026, till 48 hours after the declaration of unaudited financial results.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd-$ announced voting results and scrutinizer report for its 89th Annual General Meeting. The meeting was held on September 23, 2026, through video conferencing. The company declared a final dividend of Rs. 2.90/- per equity share for the year ended March 31, 2026. The resolutions were passed with 99.9216% to 99.9994% votes in favor. The scrutinizer's report was submitted by P SRIRAM of SPNP & ASSOCIATES.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd held its 89th Annual General Meeting (AGM) on September 23, 2026, through Video Conferencing. The meeting approved the audited financial statements, declared a final dividend of Rs. 2.90 per equity share, and re-appointed a non-executive director. The voting results will be declared and uploaded on the company's website within two working days.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has submitted its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026, as per Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has submitted its 89th Annual Report and announced its 89th Annual General Meeting to be held on 23rd September 2026 through Video Conferencing/ Other Audio Visual Means.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd-$ has released its investor presentation for the quarter ended 30th June 2026, highlighting a double-digit growth in women's hygiene, along with growth in congestion and rehydration. The company has also commissioned a new Greenfield Sanitary Napkin Manufacturing Facility in Telangana, marking a major milestone in its manufacturing journey. Several execution enhancement initiatives were implemented to improve operational effectiveness, resulting in positive momentum across key sales metrics.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has fixed 11th September, 2026 as the record date for payment of the final dividend for the financial year 2025-26.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd. has announced its financial results for the quarter ended June 30, 2026, along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company. The Board of Directors has approved the unaudited financial results and has fixed the record date for determining the eligibility of shareholders to vote on the resolutions proposed at the 89th Annual General Meeting (AGM) of the Company as Friday, September 11, 2026.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has filed an additional explanation for a corporate announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding a credit rating received from Care Ratings Limited, citing unavoidable circumstances due to the unavailability of the KMP and a need to maintain governance standards.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve the Unaudited Financial Results for the quarter ended 30th June 2026.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has commissioned a new sanitary napkin manufacturing facility in Telangana, with a ₹150 crore investment and a planned annual production capacity of 700 million sanitary napkins.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd. has announced that CARE Ratings Limited has assigned a credit rating of 'CARE A; Stable' to the company. The rating is based on the company's established track record, strong brand recall, and diversified product portfolio. The rating outlook is stable, reflecting CARE Ratings' expectation of sustained operational performance in the medium term.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from DSP Trustee Pvt Ltd & Others.

Amrutanjan Health Care Ltd-$

Amrutanjan Health Care Ltd has paid lease rent arrears to Kapaleeswarar Temple as per the order of the Hon'ble Madras High Court.